Inflamatory Bowel Disease Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD)
Inflamatory Bowel Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT07487311
Recruiting
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)Inflamatory Bowel Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University60 enrolled1 locationNCT07487480